Allied Market Research

2024

Helicobacter Pylori (h. Pylori) Non-invasive Testing Market

Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size, Share, Competitive Landscape and Trend Analysis Report by Test Type (Serology Test, Stool Antigen Test (SAT), Urea Breath Test (UBT)), by Test Method (Laboratory based Test, Point-of-Care Test) and by End User (Hospitals, Clinics, Diagnostic Laboratories): Global Opportunity Analysis and Industry Forecast, 2023-2032

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Helicobacter pylori (H. pylori) non-invasive testing is primarily used for an infection in the body when an H. pylori bacterium infects an individual's stomach. H. pylori is a spiral-shaped gram-negative aerobic bacterium developed in the digestive tract and has susceptibility to infect the stomach. H. pylori causes stomach infections when it enters and colonizes the stomach lining. Gastritis and peptic ulcers can result from these infections.

COVID-19 Impact Analysis

The current COVID-19 outbreak has had a substantial influence on the helicobacter pylori (H. pylori) non-invasive testing market owing to the presence of H. pylori in COVID-19 patients, causing abdominal pain and diarrhea. The COVID-19 virus enters cells through binding angiotensin-converting enzyme-2 (ACE-2) receptors, and H. pylori have been found to increase the expression of ACE-2 receptors in the gastrointestinal tract. Clinical investigations have shown that the incidence of diarrhea ranges from 2% to 50%, with an average of 10% associated with the COVID-19 infection. These bacteria help to reduce the hyper inflammation, which is common in COVID-19 patients.

Human leukocyte antigen has been linked to H. pylori-mediated gastric cancer. As a result, they play an important role in the development of COVID-19-related gastrointestinal symptoms. People infected with H. pylori have been reported in research trials to have more severe digestive system discomfort if they get infected with the virus. For instance, doctors highly advised patients with helicobacter to seek immediate care to avoid stomach problems if they get infected. As a result of the substantial association between H. pylori and COVID-19, the increasing demand for Helicobacter pylori (H. pylori) non-invasive testing is predicted to positively impact its market revenue.

Top Impacting Factors

  • The increase in the use of non-invasive testing for the diagnosis of H. pylori and the scarcity of endoscopic facilities are expected to drive the demand for helicobacter pylori (H. pylori) non-invasive tests.
  • The rise in government awareness of infection for accurate diagnosis, surge in demand for point-of-care testing equipment, and easy availability of diagnostics tests are the primary factors that drive the growth of the helicobacter pylori (H. pylori) non-invasive testing market.
  • The rise in the frequency of helicobacter pylori bacterial infection and new product launches and FDA approvals are expected to drive the helicobacter pylori (H. pylori) non-invasive testing market in the coming years.
  • The surge in the number of individuals suffering from gastric ulcers and the increase in the prevalence of the elderly population globally are anticipated to drive the helicobacter pylori (H. pylori) non-invasive testing market forward.
  • On the other hand, he rise in technological advancements and the number of innovations, together are anticipated to contribute in the expansion of the helicobacter pylori (H. pylori) non-invasive testing market during the forecast period.
  • However, obstacles such as a poor detection rate, the asymptomatic nature of the infection, and stringent regulatory standards are expected to hinder the helicobacter pylori (H. pylori) non-invasive testing market.

Market Trends

New Product Launches to Flourish Helicobacter Pylori (H. Pylori) Non-invasive Testing Market

In February 2019, Exalenz Bioscience Ltd. announced that the China Food and Drug Administration has permitted Exalenz to initiate marketing and sell its BreathID Hp Lab System for detection of H. pylori bacteria.

In October 2018, DiaSorin and Meridian Bioscience, Inc. strategically collaborated to sell DiaSorin’s FDA-cleared helicobacter pylori stool antigen test to identify H. pylori for use on its automated LIAISON platform under the brand, Meridian.

Key Benefits of Report

  • This study presents the analytical depiction of the helicobacter pylori (H. pylori) non-invasive testing along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the helicobacter pylori (H. pylori) non-invasive testing market share.
  • The current market is quantitatively analyzed to highlight the helicobacter pylori (H. pylori) non-invasive testing market growth scenario. 
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the helicobacter pylori (H. pylori) non-invasive testing market. 
  • The report provides a detailed helicobacter pylori (H. pylori) non-invasive testing market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions Answered in Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Report

  • Who are the leading market players active in the helicobacter pylori (H. pylori) non-invasive testing market?
  • What current trends will influence the helicobacter pylori (H. pylori) non-invasive testing market in the next few years?
  • What are the driving factors, restraints, and opportunities in the helicobacter pylori (H. pylori) non-invasive testing market?
  • What future projections would help in taking further strategic steps?
  • What is helicobacter pylori (H. pylori) non-invasive testing? 
  • What is helicobacter pylori (H. pylori) non-invasive testing market prediction for the future?
  • Who are the leading global players in the helicobacter pylori (H. pylori) non-invasive testing market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the helicobacter pylori (H. pylori) non-invasive testing market report?                           

Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Report Highlights

Aspects Details
Helicobacter Pylori (H. Pylori) Non-invasive Testing Market By Test Type
By Test Type
  • Serology Test
  • Stool Antigen Test (SAT)
  • Urea Breath Test (UBT)
Helicobacter Pylori (H. Pylori) Non-invasive Testing Market By Test Method
By Test Method
  • Laboratory based Test
  • Point-of-Care Test
Helicobacter Pylori (H. Pylori) Non-invasive Testing Market By End User
By End User
  • Hospitals
  • Clinics
  • Diagnostic Laboratories
Helicobacter Pylori (H. Pylori) Non-invasive Testing Market By Region
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players
Key Market Players

Biomerica, Inc, Exalenz Bioscience Ltd., Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd., Meridian Bioscience, Inc., Sekisui Diagnostics, Thermo Fisher Scientific, CorisBioconcept SPRL, Certest Biotec S.L, Alere, DiaSorin S.p.A.

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Helicobacter Pylori (h. Pylori) Non-invasive Testing Market

Global Opportunity Analysis and Industry Forecast, 2023-2032